Company Filing History:
Years Active: 2015-2018
Title: Paul Mason: Innovator in Therapeutic Compounds
Introduction
Paul Mason is a notable inventor based in Natick, MA (US). He has made significant contributions to the field of therapeutic compounds, holding a total of 3 patents. His work focuses on innovative solutions for metabolic diseases and cancer treatment.
Latest Patents
Mason's latest patents include groundbreaking inventions such as NAMPT inhibitors and methods. This invention features compounds of Formula (I), Formula (I)-A, and Formula (I)-B, along with methods of synthesis, therapy, diagnostics, and assays. Another significant patent is related to glucosylceramide synthase inhibitors. This invention pertains to inhibitors of glucosylceramide synthase (GCS), which are useful for treating metabolic diseases, including lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, as well as for cancer treatment.
Career Highlights
Paul Mason is currently associated with Genzyme Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating therapies that address critical health issues.
Collaborations
Mason collaborates with talented individuals such as Elyse Bourque and Bradford Hirth, contributing to a dynamic research environment that fosters innovation.
Conclusion
In summary, Paul Mason is a dedicated inventor whose work in therapeutic compounds has the potential to significantly impact the treatment of metabolic diseases and cancer. His contributions to the field are noteworthy and continue to inspire advancements in medical science.